2nd International Conference on
Infectious Diseases
"Innovative Treatment for Infectious Diseases"
Paper/Abstract Submission Deadline :
Call for Papers
As a Scientific Research Conference Organizer, The Global Academic Research Institute is proudly organizing the International Conference on Infectious Diseases (ICID 2026) under the theme of “Innovative Treatment for Infectious Diseases”. We welcome proposals for papers and invitations for abstract submissions are now open for both Oral and Poster presentations covering current research and new processes. All contributions should be of high quality. During the review period, Papers will be reviewed by eminent scholars in the respective areas.
Two types of submissions are invited:
01. Full papers reporting on original & unpublished research
02. Work-in-progress papers or Abstract or Case Studies or Projects
The conference aims to provide a platform for academics, researchers, professionals, administrators, educational leaders, policymakers, industry representatives, advanced students, and anyone in the domain of interest from around the world to discuss Community Medicine and Public Health. Please note that speakers are encouraged to submit a full paper before the conference. In addition, all the submitted full papers will be reviewed by the journal editorial board and a few high-end papers will be published in GARI e-Journal having ISSN & DOI, and All Selected papers will be published in conference printed proceedings having ISBN as well as a conference library page.
For abstract submission fill in the online submission form or contact helpdesk@gariteam.com. Presentation time allocated 20 mins (15 mins presentation 05 mins questions),
All Selected papers will be published in different Journals
GARI International Journal of Multidisciplinary Research (www.research.lk) International Journal of Health and Medicine (Online: ISSN 2424-6476) International Journal of Food Science (Online: ISSN 2513-2636) as well as GARI Digital Research Library,
Print & Online proceedings Book will include "Extended Abstracts", should be at least three pages, but not more than five pages in length including the references. The word limit is 1000 - 1200 words.
Note - Offer certificate for co-authors & All Participant Delegates
Virtual Delegate Presentation (via ZOOM platform) is available at the conference & All the presentations LIVE STREAM on Facebook. After the event, We post the Print Certificate & Proceeding after the Conference
Important Dates
- Paper/Abstract submission deadline : 30th June 2026
- Notification of acceptance : Within 21 Days (+/-3)
- Full paper submission deadline : 31st August 2026
- Registration Deadline : 6th August 2026
- Conference Date :
Scope
Emerging & Re-emerging Infectious Diseases
- COVID-19: Post-pandemic surveillance, long COVID & lessons learned
- Ebola, Marburg & other viral hemorrhagic fevers
- Zika, Chikungunya, Dengue & other arboviruses
- Mpox (monkeypox), Nipah & Hendra viruses
- Influenza (avian, swine, seasonal & pandemic strains)
- Emerging zoonotic diseases & spillover events
- Re-emergence of vaccine-preventable diseases (measles, polio, pertussis)
- Antimicrobial-resistant (AMR) pathogens as emerging threats
HIV/AIDS, Tuberculosis & Malaria
- HIV prevention, treatment & cure research
- Pre-exposure prophylaxis (PrEP) & post-exposure prophylaxis (PEP)
- HIV drug resistance & antiretroviral therapy (ART) optimization
- Tuberculosis: Drug-sensitive, multidrug-resistant (MDR-TB) & extensively drug-resistant (XDR-TB)
- TB-HIV co-infection management
- Malaria control: Vector management, diagnostics & artemisinin-based combination therapies (ACTs)
- Malaria vaccine development & deployment (RTS,S/ R21)
- Elimination strategies for HIV, TB & malaria by 2030
Antimicrobial Resistance (AMR) & Stewardship
- Mechanisms of antimicrobial resistance (bacterial, viral, fungal, parasitic)
- Methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE) & vancomycin-resistant Enterococci (VRE)
- Extended-spectrum beta-lactamases (ESBL) & multidrug-resistant (MDR) organisms
- Antibiotic stewardship programs in hospitals & communities
- Surveillance systems for AMR (GLASS, TRACSS)
- Novel antibiotics, phage therapy & alternative antimicrobials
- Antimicrobial use in agriculture & food systems (One Health AMR)
- Policy, regulation & global action plans on AMR
Vaccine Development & Immunization
- Vaccine platforms: mRNA, viral vector, subunit, inactivated & live-attenuated
- COVID-19 vaccines: Efficacy, safety, variants & booster strategies
- Next-generation vaccines for HIV, TB, malaria & universal influenza
- Maternal & childhood immunization programs
- Vaccine hesitancy, acceptance & communication strategies
- Cold chain, logistics & vaccine delivery in low-resource settings
- Therapeutic vaccines for chronic infections (hepatitis B, HPV, cancer)
- Global vaccine equity & COVAX mechanism
Diagnostics, Surveillance & Laboratory Science
- Rapid diagnostic tests (RDTs) & point-of-care (POC) diagnostics
- Molecular diagnostics: PCR, multiplex panels, next-generation sequencing (NGS)
- CRISPR-based diagnostics & isothermal amplification methods
- Biosurveillance systems & real-time outbreak detection
- Genomic epidemiology & pathogen sequencing for outbreak tracking
- Wastewater surveillance for infectious disease monitoring
- Artificial intelligence & machine learning for outbreak prediction
- Laboratory biosafety, biosecurity & quality assurance systems
Infection Prevention & Control (IPC)
- Healthcare-associated infections (HAIs) & hospital-acquired infections
- Hand hygiene, personal protective equipment (PPE) & environmental cleaning
- Isolation precautions, cohorting & ventilation in healthcare settings
- Surgical site infections (SSIs), catheter-associated infections & ventilator-associated pneumonia (VAP)
- IPC in long-term care facilities, schools & congregate settings
- Outbreak preparedness & response in healthcare facilities
- IPC training, auditing & behavior change strategies
- Role of IPC in antimicrobial resistance containment
One Health, Zoonoses & Global Health Security
- Zoonotic spillover: Drivers, interfaces & prevention
- Rabies, brucellosis, leptospirosis, anthrax & other endemic zoonoses
- Vector-borne diseases: Mosquito, tick, flea & sandfly-borne infections
- Foodborne & waterborne diseases (salmonella, cholera, E. coli, norovirus)
- Climate change & infectious disease transmission dynamics
- Pandemic preparedness, International Health Regulations (IHR) & WHO
- Global health security agenda & financing for outbreak response
- Cross-sectoral collaboration (human, animal, environmental health)
Registration Fees
| Foreign | Amount |
| Delegate Presenter / Author (Oral) | 290 USD |
| Delegate Student Presenter / Author (Oral) | 260 USD |
| Virtual Delegate | 230 USD |
| Accompanying Person / Delegate Listener | 260 USD |
| E-Poster Presentation (Remote Delegate) | 175 USD |